SPECT
SPECT is an intervention with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
87.5%
7 of 8 finished
12.5%
1 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function
[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor
Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3
Post-RAI Therapy Dosimetry and Quality Assessment of Target Tissue Dosing
Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2.
Clinical Trials (10)
Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function
[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor
Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3
Post-RAI Therapy Dosimetry and Quality Assessment of Target Tissue Dosing
Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2.
68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO)
Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3
99mTc-ADAPT6-based HER2 Imaging in Breast Cancer
Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease-2
Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease
All 10 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 10